Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Semjonow

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
BMC Medical Informatics and Decision Making|February 18, 2011
HIS-based Kaplan-Meier plots--a single source approach for documenting and reusing routine survival informationBernhard Breil, Axel Semjonow, Carsten Müller-Tidow, et al.
British Journal of Cancer|September 22, 2023
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategiesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Health Informatics Journal|June 27, 2019
Combination possibility and deep learning model as clinical decision-aided approach for prostate cancerOkyaz Eminaga, Omran Al-Hamad, Martin Boegemann, et al.
Cancers|January 8, 2023
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology OutcomesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Clinical Chemistry|December 6, 2012
Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancerCarsten Stephan, Sébastien Vincendeau, Alain Houlgatte, et al.
Cancer Research|September 20, 2006
Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN geneHartmut Schmidt, Gabriela DeAngelis, Elke Eltze, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|December 8, 2016
[Results of a psychooncological group intervention in male cancer patients aged 60 years or older]Gudrun Schneider, Birgit Kropff, Michael Unrath, et al.
BMC Cancer|April 9, 2022
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamideRenata Poteska, Kambiz Rahbar, Axel Semjonow, et al.
The Journal of Urology|November 25, 2003
Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancerKlaus Jung, Carsten Stephan, Axel Semjonow, et al.
Clinical Biochemistry|May 11, 2010
Pre-analytical in-vitro stability of [-2]proPSA in blood and serumAxel Semjonow, Thomas Köpke, Elke Eltze, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
BMC Medical Informatics and Decision Making|February 18, 2011
HIS-based Kaplan-Meier plots--a single source approach for documenting and reusing routine survival informationBernhard Breil, Axel Semjonow, Carsten Müller-Tidow, et al.
British Journal of Cancer|September 22, 2023
Loss of PDE4D7 expression promotes androgen independence, neuroendocrine differentiation and alterations in DNA repair: implications for therapeutic strategiesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Health Informatics Journal|June 27, 2019
Combination possibility and deep learning model as clinical decision-aided approach for prostate cancerOkyaz Eminaga, Omran Al-Hamad, Martin Boegemann, et al.
Cancers|January 8, 2023
The CAPRA&PDE4D5/7/9 Prognostic Model Is Significantly Associated with Adverse Post-Surgical Pathology OutcomesChloe Gulliver, Sebastian Huss, Axel Semjonow, et al.
Clinical Chemistry|December 6, 2012
Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancerCarsten Stephan, Sébastien Vincendeau, Alain Houlgatte, et al.
Cancer Research|September 20, 2006
Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN geneHartmut Schmidt, Gabriela DeAngelis, Elke Eltze, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|December 8, 2016
[Results of a psychooncological group intervention in male cancer patients aged 60 years or older]Gudrun Schneider, Birgit Kropff, Michael Unrath, et al.
BMC Cancer|April 9, 2022
The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamideRenata Poteska, Kambiz Rahbar, Axel Semjonow, et al.
The Journal of Urology|November 25, 2003
Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancerKlaus Jung, Carsten Stephan, Axel Semjonow, et al.
Clinical Biochemistry|May 11, 2010
Pre-analytical in-vitro stability of [-2]proPSA in blood and serumAxel Semjonow, Thomas Köpke, Elke Eltze, et al.
Pageof 11